Legend Biotech Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Legend Biotech Corporation
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Somerset
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LEGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001801198
Board of directors
-
Corazon (Corsee) D. Sanders · DirectorSince 2026
-
Darren Xiaohui Ji · DirectorSince 2026
-
Fangliang Zhang · DirectorSince 2026
-
Gareth Kung · DirectorSince 2026
-
Li Mao · DirectorSince 2026
-
Patrick John Casey · DirectorSince 2026
-
Peter Salovey · DirectorSince 2026
-
Robin Meng · DirectorSince 2026
-
Tomas J. Heyman · DirectorSince 2026
-
Ye Wang · DirectorSince 2026
-
Ying Huang · Director · Chief Executive OfficerSince 2026
Chief executives
Ying Huang
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 7 other boards.
- via Corazon (Corsee) D. Sanders
- via Corazon (Corsee) D. Sanders
- via Tomas J. Heyman
- via Tomas J. Heyman
- via Ying Huang
- via Corazon (Corsee) D. Sanders
- via Tomas J. Heyman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $307,834
- 4 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 21, 2026 | Santos Carlos E Officer (Chief Financial Officer) | Grant or award | +19,676 | — | — |
| Sep 21, 2026 | Santos Carlos E Officer (Chief Financial Officer) | Open-market sale | −5,430 | $9.14 | $49,630 |
| Sep 15, 2026 | Ingrid Zhang Officer (Chief Executive Officer) | Grant or award | +1,131,860 | — | — |
| Aug 14, 2026 | BASH ALAN Officer (Interim CEO) | Grant or award | +4,908 | — | — |
| Jun 30, 2026 | Patrick John Casey Director | Open-market sale | −6,000 | $14.80 | $88,800 |
| Jun 30, 2026 | Ying Huang Director, Officer (Chief Executive Officer) | Gift | −3,382 | — | — |
| Jun 25, 2026 | Ying Huang Director, Officer (Chief Executive Officer) | Open-market sale | −5,566 | $14.78 | $82,265 |
| Mar 25, 2026 | Ying Huang Director, Officer (Chief Executive Officer) | Open-market sale | −9,936 | $8.77 | $87,139 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.